Carlisle Companies Incorporated Revenue Growth Rates (CSL), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Carlisle Companies Incorporated  (NYSE: CSL)
 

CSL's Revenue Growth by Quarter and Year

Carlisle Companies Incorporated's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CSL Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 1,570.30
1st Quarter March 1,052.10
FY 2,622.40

CSLs Annual Revenue
Carlisle Companies Incorporated's Revenue in the fiscal year 2025 $ 5,019.90 millions
Carlisle Companies Incorporated's Revenue in the fiscal year 2024 $ 5,003.60 millions
Carlisle Companies Incorporated's Revenue in the fiscal year 2023 $ 4,586.90 millions
Carlisle Companies Incorporated's Revenue in the fiscal year 2022 $ 6,591.90 millions
Carlisle Companies Incorporated's Revenue in the fiscal year 2021 $ 4,810.30 millions




CSL Revenue second quarter 2026 Y/Y Growth Comment
Carlisle Companies Incorporated achieved in the second quarter 2026, above Company average Revenue improvement of 8.33% year on year, to $ 1,570.30 millions.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 138 other companies have achieved higher Revenue growth. While Carlisle Companies Incorporated' s Revenue increase of 8.33% ranks overall at the positon no. 2626 in the second quarter 2026.


CSL Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 0.43 % -0.41 % -22.49 %
3rd Quarter September - 1 % 5.86 % -15.85 %
2nd Quarter June 8.33 % -0.08 % 10.99 % -16.34 %
1st Quarter March -3.99 % -0.06 % 22.84 % -28.03 %
FY   - 0.33 % 9.08 % -

Financial Statements
Carlisle Companies Incorporated's second quarter 2026 Revenue $ 1,570.30 millions CSL's Income Statement
Carlisle Companies Incorporated's second quarter 2025 Revenue $ 1,449.50 millions Quarterly CSL's Income Statement


CSL Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - -16.27 % -15.8 % -10.5 %
3rd Quarter September - -7.08 % -8.07 % -3.61 %
2nd Quarter June 49.25 % 32.28 % 32.29 % 46.43 %
1st Quarter March -6.7 % -2.41 % -2.75 % -38.64 %
FY (Year on Year)   - 0.33 % 9.08 % -


Back to CSL Growth rate Comparisons >> Back to CSL Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #139
Healthcare Sector #379
Overall #2626

Revenue Y/Y Growth Statistics
High Average Low
40.09 % 5.38 % -22.75 %
(Sep 30 2022)   (Dec 31 2023)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #139
Healthcare Sector #379
Overall #2626
Revenue Y/Y Growth Statistics
High Average Low
40.09 % 5.38 % -22.75 %
(Sep 30 2022)   (Dec 31 2023)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Carlisle Companies Incorporated's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
49.25 % 2.85 % -25.27 %
(Jun 30 2026)  


CSL's II. Quarter Q/Q Revenue Comment
Carlisle Companies Incorporated achieved in the II. Quarter 2026 above company average sequential Revenue jump of 49.25%, to $ 1,570.30 millions, from $1,052.10 millions in the first quarter.
CSL is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 14 other companies have achieved higher Revenue quarter on quarter growth. While Carlisle Companies Incorporated's Revenue growth quarter on quarter, overall rank is 243.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #15
Healthcare Sector #66
Overall #243
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #15
Healthcare Sector #66
Overall #243
Revenue Q/Q Growth Statistics
High Average Low
49.25 % 2.85 % -25.27 %
(Jun 30 2026)  


CSL's II. Quarter Q/Q Revenue Comment
Carlisle Companies Incorporated achieved in the II. Quarter 2026 above company average sequential Revenue jump of 49.25%, to $ 1,570.30 millions, from $1,052.10 millions in the first quarter.
CSL is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 14 other companies have achieved higher Revenue quarter on quarter growth. While Carlisle Companies Incorporated's Revenue growth quarter on quarter, overall rank is 243.


Carlisle Companies Incorporated's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 5,097.00 $ 4,976.20 $ 5,019.90 $ 5,015.10 $ 5,001.80
Y / Y Revenue Growth (TTM) 1.9 % -0.53 % 0.33 % 0.14 % 1.37 %
Year on Year Revenue Growth Overall Ranking # 2491 # 2446 # 2725 # 1389 # 2840
Seqeuential Revenue Change (TTM) 2.43 % -0.87 % 0.1 % 0.27 % -0.02 %
Seq. Revenue Growth (TTM) Overall Ranking # 2626 # 2464 # 2446 # 2486 # 1490


Cumulative Revenue growth Comment
Although Carlisle Companies Incorporated's Annual Revenue growth year on year were below company's average 5.38% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 1.9% year on year, from -0.53% in Mar 31 2026.

In the Healthcare sector 357 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2446 to 2491.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 139
Healthcare Sector # 358
Overall # 2491

Revenue TTM Y/Y Growth Statistics
High Average Low
40.09 %
 5.38 %
-22.75 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 139
Sector # 379
S&P 500 # 2626
Cumulative Revenue growth Comment
Although Carlisle Companies Incorporated's Annual Revenue growth year on year were below company's average 5.38% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 1.9% year on year, from -0.53% in Mar 31 2026.

In the Healthcare sector 357 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2446 to 2491.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 139
Healthcare Sector # 358
Overall # 2491

Revenue TTM Y/Y Growth Statistics
High Average Low
40.09 %
5.38 %
-22.75 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 139
Sector # 379
S&P 500 # 2626




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CSL's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Sbc Medical Group Holdings Incorporated14.36%$ 14.363 millions
Nuwellis Inc 14.14%$ 14.145 millions
West Pharmaceutical Services Inc 13.89%$ 13.892 millions
Edwards Lifesciences Corporation13.66%$ 13.657 millions
Indivior Pharmaceuticals Inc 13.58%$ 13.576 millions
Talkspace Inc 13.56%$ 13.556 millions
Atricure Inc 13.38%$ 13.376 millions
Dexcom Inc 13.11%$ 13.105 millions
Sanara Medtech Inc 13.03%$ 13.028 millions
Bausch Health Companies Inc 12.73%$ 12.727 millions
Vertex Pharmaceuticals Inc12.45%$ 12.453 millions
Genedx Holdings Corp 12.30%$ 12.304 millions
Profound Medical Corp 12.30%$ 12.302 millions
Xenetic Biosciences Inc 11.99%$ 11.986 millions
Biolife Solutions Inc 11.98%$ 11.978 millions
Repligen Corp11.93%$ 11.933 millions
Medline Inc 11.60%$ 11.603 millions
Earth Science Tech Inc 11.56%$ 11.556 millions
Immucell Corporation11.50%$ 11.501 millions
Harrow Inc 11.26%$ 11.256 millions
Rapid Micro Biosystems Inc 10.91%$ 10.906 millions
Livanova Plc10.80%$ 10.797 millions
Cerus Corporation10.52%$ 10.517 millions
Interpace Biosciences Inc 10.33%$ 10.331 millions
Warby Parker Inc 10.25%$ 10.253 millions
Neuronetics Inc 10.25%$ 10.249 millions
Elanco Animal Health Incorporated10.23%$ 10.234 millions
Quest Diagnostics Inc10.21%$ 10.214 millions
Gilead Sciences Inc 10.18%$ 10.181 millions
Lifeloc Technologies Inc 10.16%$ 10.163 millions


About Carlisle Companies Incorporated Revenue Growth Rates (CSL), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Carlisle Companies Inc (CIK 790051).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000790051-26-000037
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Carlisle Companies Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.